advertisement
Song Z 28
Showing records 1 to 25 | Display all abstracts from Song Z104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu X
Eye 2023; 37: 607-617
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Khan M
Ocular Immunology and Inflammation 2022; 0: 1-11
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhang B
Eye 2023; 37: 607-617
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Yao B
British Journal of Ophthalmology 2023; 107: 1458-1466
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Shah S; Lv B
Ocular Immunology and Inflammation 2022; 0: 1-11
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li X
Eye 2023; 37: 607-617
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Yang X
British Journal of Ophthalmology 2023; 107: 1458-1466
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li M
Eye 2023; 37: 607-617
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Lv Z
Ocular Immunology and Inflammation 2022; 0: 1-11
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wang Y
Eye 2023; 37: 607-617
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Ji N
Ocular Immunology and Inflammation 2022; 0: 1-11
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Liu Y
British Journal of Ophthalmology 2023; 107: 1458-1466
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Song Z
Ocular Immunology and Inflammation 2022; 0: 1-11
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Xie Z
British Journal of Ophthalmology 2023; 107: 1458-1466
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Dan H
Eye 2023; 37: 607-617
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Wu P
Ocular Immunology and Inflammation 2022; 0: 1-11
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhou J
Eye 2023; 37: 607-617
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Chen X
British Journal of Ophthalmology 2023; 107: 1458-1466
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Wang X
Ocular Immunology and Inflammation 2022; 0: 1-11
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wei Y
Eye 2023; 37: 607-617
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Yuan Z; Wang X
British Journal of Ophthalmology 2023; 107: 1458-1466
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Ge K
Eye 2023; 37: 607-617
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Mehmood A
Ocular Immunology and Inflammation 2022; 0: 1-11
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Hu D
British Journal of Ophthalmology 2023; 107: 1458-1466
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li P
Eye 2023; 37: 607-617
